Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M
Abbott Laboratories (NYSE:ABT) agrees to acquire Cardiovascular Systems Inc (NASDAQ:CSII) for $20/share for an equity value of approximately $890 million. CSI offers…